{"title":"Synthesis, transformations and biological evaluation of 5‑chloro-8-hydroxyquinoline hybrids","authors":"Dóra Hegedűs , Nikoletta Szemerédi , Dorka Gubó , Gabriella Spengler , István Szatmári","doi":"10.1016/j.ejps.2025.107084","DOIUrl":null,"url":null,"abstract":"<div><div>Taking in consideration of previous studies in the field of biological relevance and the chelating properties of derivatives bearing the hydroxyquinoline skeleton, establishing cationic centre by direct amidation as well as preparation compound with amino acid character was proposed. In order to test anticancer activity of the synthesised compounds, the applying of preliminary biological screening systems was planned. This concept is demonstrated in the context of the synthesis and transformation of a bifunctional glycine-type precursor substituted with 5‑chloro-8-hydroxyquinoline to hybrids with amino acid and amine feature. Stabilization of the precursor and formed amide composed of <em>N,N</em>-dimethylethylamine via partially aromatic <em>ortho</em>-quinone methide intermediate was tested with different cyclic imines in [4 + 2] cycloaddition. In these [4 + 2] cycloaddition reactions, <sup>1</sup>H NMR analysis of the crude reaction mixture proved the formation of a single product in all cases. The relative configuration of the two newly formed stereogenic centres was determined by 2D-NMR technique. Compared to the precursor, all new derivatives exhibited less potent anticancer activity. Based on biological evaluations, out of the synthesized compounds the derivative with amino acid feature and some amidated derivatives showed toxic activity against the Colo 205 cell line.</div></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"209 ","pages":"Article 107084"},"PeriodicalIF":4.3000,"publicationDate":"2025-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutical Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0928098725000831","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Taking in consideration of previous studies in the field of biological relevance and the chelating properties of derivatives bearing the hydroxyquinoline skeleton, establishing cationic centre by direct amidation as well as preparation compound with amino acid character was proposed. In order to test anticancer activity of the synthesised compounds, the applying of preliminary biological screening systems was planned. This concept is demonstrated in the context of the synthesis and transformation of a bifunctional glycine-type precursor substituted with 5‑chloro-8-hydroxyquinoline to hybrids with amino acid and amine feature. Stabilization of the precursor and formed amide composed of N,N-dimethylethylamine via partially aromatic ortho-quinone methide intermediate was tested with different cyclic imines in [4 + 2] cycloaddition. In these [4 + 2] cycloaddition reactions, 1H NMR analysis of the crude reaction mixture proved the formation of a single product in all cases. The relative configuration of the two newly formed stereogenic centres was determined by 2D-NMR technique. Compared to the precursor, all new derivatives exhibited less potent anticancer activity. Based on biological evaluations, out of the synthesized compounds the derivative with amino acid feature and some amidated derivatives showed toxic activity against the Colo 205 cell line.
期刊介绍:
The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development.
More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making.
Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.